According to Glaukos's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 15.8645. At the end of 2023 the company had a P/S ratio of 12.3.
Year | P/S ratio | Change |
---|---|---|
2023 | 12.3 | 67.32% |
2022 | 7.37 | 3.94% |
2021 | 7.09 | -52.88% |
2020 | 15.0 | 50.44% |
2019 | 10.00 | -10.63% |
2018 | 11.2 | 100.96% |
2017 | 5.57 | -44.66% |
2016 | 10.1 | -9.23% |
2015 | 11.1 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ICU Medical
ICUI | 1.02 | -93.55% | ๐บ๐ธ USA |
AtriCure ATRC | 2.81 | -82.30% | ๐บ๐ธ USA |
Integra LifeSciences IART | 1.45 | -90.89% | ๐บ๐ธ USA |
Hill-Rom HRC | N/A | N/A | ๐บ๐ธ USA |